Welcome!

Weblogic Authors: Jnan Dash, Michael Bushong, Avi Rosenthal

News Feed Item

TAKE Solutions Achieves Oracle PartnerNetwork Specialization for Oracle Argus Safety Suite Technology

CHENNAI, November 26, 2012 /PRNewswire/ --

TAKE Solutions Ltd. [BSE: 532890 | NSE: TAKE], a leader in the Supply Chain Management (SCM) and Life Sciences (LS) domains and a Gold level member of Oracle® PartnerNetwork (OPN), today announced that it has achieved OPN Specialized status for Oracle Argus Safety Suite.

To achieve a Specialized status, Oracle partners are required to meet a stringent set of requirements that are based on the needs and priorities of the customer and partner community. By achieving a Specialized distinction, TAKE Solutions has been recognised by Oracle for its expertise in delivering services specifically around Oracle Argus Safety Suite through competency development, business results and proven success.  

Achieving the Specialization for Oracle Argus Safety Suite demonstrates TAKE's proficiency in Oracle's drug safety and pharmacovigilance solution, as well as its overall commitment to Oracle Health Sciences applications.

Ram Yeleswarapu, President and CEO, TAKE Solutions stated, "This is a significant milestone for TAKE Solutions. We are thankful for the recognition by Oracle and our clients in our commitment to Oracle Argus Safety Suite in the area of drug safety and pharmacovigilance. We are confident that our clients can benefit from these innovative systems."

"By achieving Specialization for Oracle Argus Safety Suite, TAKE Solutions has demonstrated an expertise and understanding of Oracle Health Sciences software that can provide significant benefits for customers. We congratulate TAKE Solutions on its OPN Specialization," said Neil de Crescenzo, Senior Vice President and General Manager, Oracle Health Sciences.

About Oracle PartnerNetwork:

Oracle PartnerNetwork (OPN) Specialized is the latest version of Oracle's partner program that provides partners with tools to better develop, sell and implement Oracle solutions. OPN Specialized offers resources to train and support specialised knowledge of Oracle products and solutions and has evolved to recognize Oracle's growing product portfolio, partner base and business opportunity. Key to the latest enhancements to OPN is the ability for partners to differentiate through Specializations. Specializations are achieved through competency development, business results, expertise, and proven success. To find out more, visit oracle.com/partners.

About TAKE Solutions:

TAKE Solutions, Ltd. [BSE: 532890 | NSE: TAKE] is a leading global business technology company with domain expertise in Life Sciences (LS) and Supply Chain Management (SCM). TAKE provides cost-effective and comprehensive solutions for enterprises across diverse sectors including pharmaceuticals, high technology, consumer packaged goods, oil/gas, and automotive. TAKE's SCM product suites include distinct technology with embedded IP that spans enterprise mobility, trading partner collaboration, and material tracking. In the LS domain, TAKE offers IP-based software and extensive knowledge-based solutions to enable efficient clinical, regulatory, safety and commercialisation processes.

TAKE has been recognised as a leader by IDC's MarketScape Worldwide Life Sciences R&D IT Outsourcing for 2011. TAKE's global headquarters is in Chennai, India; its U.S. headquarters is located in Princeton, New Jersey. TAKE has a proven track record as a trusted partner in delivering world-class solutions to more than 400 customers worldwide. For more information, please visit: www.takesolutions.com.

Trademarks

Oracle and Java are registered trademarks of Oracle and/or its affiliates.

Primary Media Contact: Annapoorna K, [email protected], 91-44-45909185

Secondary Media Contact: Twinkle Xavier, [email protected], 91-9884480115

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.